Presented by Shawn Levy, PhD (Discovery Life Sciences)

NOVEMBER 17, 2020
 

The ability to reliably detect and characterize the spectrum of sequence variants observed in the human genome is critical for understanding the role of mutation and variation in genetic risk and phenotype.  Scaled CCS analysis on the Pacific Biosciences Sequel II platform supports efficient and reliable detection of complex and simple variants in diverse populations at high accuracy and enabling coverage.

 

Ask Your Questions

Have a question related to this presentation? Submit this form and we will get you answers.